Injection/Infusion
ZERBAXA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/0.5G
Summary
ZERBAXA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/0.5G — Injection/Infusion containing ceftolozane (as sulfate), tazobactam (as sodium). Hong Kong Registration No. HK-65156. Certificate Holder: MERCK SHARP & DOHME (ASIA) LTD. Date of Registration: 23 May, 2017.
Product NameZERBAXA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1G/0.5G
Registration No.HK-65156
Certificate HolderMERCK SHARP & DOHME (ASIA) LTD
Holder Address27/F, LEE GARDEN TWO 28 YUN PING ROAD, CAUSEWAY BAY, HONG KONG
Ingredientsceftolozane (as sulfate), tazobactam (as sodium)
Dosage FormInjection/Infusion
Legal ClassificationAntibiotic
Sale RequirementPrescription only Medicines
Date of Registration23 May, 2017
ATC codesJ01CG02
ATC Classification
ATC level 1
J Antiinfectives for Systemic Use
All ATC groupsJ01
This product contains more than one active ingredient. The ATC groups above describe the ingredients, not a single category for the product as a whole.
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。